82129-19-9

Upstream product

• 7677-24-9 trimethylsilyl cyanide 
• 387-45-1 2-chloro-6-fluorobenzaldehyde 

Downstream Products

• 82129-20-2 ethyl 1-(2-chloro-6-fluorophenyl)-1-hydroxymethanecarboximidate hydrochloride 
• 100947-59-9 5-[2-(benzyloxy)-6-chlorophenyl]oxazolidine-2,4-dione 
• 100947-79-3 5-{2-chloro-6-[(cyclopropylmethyl)oxy]phenyl}oxazolidine-2,4-dione 
• 100947-80-6 5-[2-chloro-6-(allyloxy)phenyl]oxazolidine-2,4-dione 
• 100947-77-1 5-[2-chloro-6-(1-pyrroolyl)phenyl]oxazolidine-2,4-dione 
• 100947-78-2 5-<2-chloro-6-(1-propenyloxy)phenyl>oxazolidine-2,4-dione 
• 82128-27-6 5-(2-chloro-6-methylthiophenyl)oxazolidine-2,4-dione 
• 82129-18-8 5-(2-chloro-6-methoxyphenyl)-oxazolidine-2,4-dione 
• 82129-21-3 5-(2-chloro-6-fluorophenyl)oxazolidine-2,4-dione 

Relevant academic research and scientific papers

FLUORINATED QUINOLINE, QUINOXALINE AND BENZO[B][1,4]OXAZINE DERIVATIVES AS DIHYDROOROTATE DEHYDROGENASE (DHODH) INHIBITORS FOR THE TREATMENT OF CANCER, AUTOIMMUNE AND INFLAMMATORY DISEASES

The present invention discloses compounds formula (I): (I) wherein X is CH; R2 is (AA) R3 is (BB) The present compounds of formula (I) are dihydroorotate dehydrogenase (DHODH) inhibitors, and are useful for the treatment of inflammatory disorders, autoimm

Hypoglycemic 5-substituted oxazolidine-2,4-diones

Hypoglycemic 5-phenyl and 5-naphthyl oxazolidine-2,4-diones and the pharmaceutically-acceptable salts thereof; certain 3-acylated derivatives thereof; a method of treating hyperglycemic animals therewith; and intermediates useful in the preparation of said compounds.